These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8522712)

  • 1. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.
    Levine JH; Massumi A; Scheinman MM; Winkle RA; Platia EV; Chilson DA; Gomes A; Woosley RL
    J Am Coll Cardiol; 1996 Jan; 27(1):67-75. PubMed ID: 8522712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
    Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
    Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.
    Fogel RI; Herre JM; Kopelman HA; Kowey PR; Trohman RG; Fineberg N; Prystowsky EN
    Am Heart J; 2000 Apr; 139(4):690-5. PubMed ID: 10740153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias.
    Naccarelli GV; Jalal S
    Circulation; 1995 Dec; 92(11):3154-5. PubMed ID: 7586296
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous amiodarone.
    Kowey PR; Marinchak RA; Rials SJ; Filart RA
    J Am Coll Cardiol; 1997 May; 29(6):1190-8. PubMed ID: 9137212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
    Yusu S; Ikeda T; Mera H; Miyakoshi M; Miwa Y; Abe A; Tsukada T; Ishiguro H; Shimizu H; Yoshino H
    Circ J; 2009 Nov; 73(11):2021-8. PubMed ID: 19724153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial.
    Saul JP; Scott WA; Brown S; Marantz P; Acevedo V; Etheridge SP; Perry JC; Triedman JK; Burriss SW; Cargo P; Graepel J; Koskelo EK; Wang R;
    Circulation; 2005 Nov; 112(22):3470-7. PubMed ID: 16316969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous antiarrhythmic drug therapy in the resuscitation from refractory ventricular arrhythmias.
    Kudenchuk PJ
    Am J Cardiol; 1999 Nov; 84(9A):52R-55R. PubMed ID: 10568660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia.
    Somberg JC; Bailin SJ; Haffajee CI; Paladino WP; Kerin NZ; Bridges D; Timar S; Molnar J;
    Am J Cardiol; 2002 Oct; 90(8):853-9. PubMed ID: 12372573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS; Kane-Gill SL; Rudis MI; Seybert AL; Oyen LJ; Ou NN; Stauss JL; Kirisci L; Idrees U; Henderson SO
    Crit Care Med; 2006 Jun; 34(6):1617-23. PubMed ID: 16614583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
    Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
    N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
    Ortiz M; Martín A; Arribas F; Coll-Vinent B; Del Arco C; Peinado R; Almendral J;
    Eur Heart J; 2017 May; 38(17):1329-1335. PubMed ID: 27354046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias.
    Schupp T; Behnes M; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Ansari U; El-Battrawy I; Bertsch T; Weiß C; Nienaber C; Lang S; Akin M; Mashayekhi K; Borggrefe M; Akin I
    Int J Cardiol; 2019 Feb; 277():118-124. PubMed ID: 30473333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias.
    Caron MF; Kluger J; White CM
    Ann Pharmacother; 2001 Oct; 35(10):1248-54. PubMed ID: 11675855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
    Wang CH; Chang WT; Huang CH; Tsai MS; Yu PH; Wu YW; Liu YB; Chen WJ
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):327-334. PubMed ID: 31255419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.